Our funding events in Drug Discovery are shown below.
The Wellcome Trust invites preliminary applications for its seeding drug discovery scheme. The aim is to develop drug-like, small molecules that will be the springboard for further research and development by the biotechnology and pharmaceutical industry. Projects must address an unmet need in healthcare or in applied medical research, offer a potential new solution, and have a realistic expectation that the innovation will be developed further by the market. It is expected that 6-9 projects will be selected to submit a full proposal and 3-4 will receive funding.
Applications require the involvement of Cambridge Enterprise. It is highly advisable to contact Cambridge Enterprise as early as possible in the process, who have experience of this scheme and can provide advice and assistance throughout the application process. Please contact Dr Iain Thomas (email@example.com) in the first instance.
Funding: There is no set size for these awards, but it is expected that most awards will be in the range of £1M-£3M and will provide support for 10-20FTEs (including contract research services, as appropriate). Project duration will be determined by how advanced the candidate compounds have to be to have a good prospect of attracting third-party funding. It is, however, expected that projects will last no longer than three years.
Eligibility: Applicants should normally hold a position of responsibility within the University and be able to sign up or comply with the conditions or terms of an award. Postdoctoral research assistants are eligible for co-applicant status if they make a significant contribution to a research proposal and have agreement from their funding agency. Researchers from disciplines outside biomedicine can apply providing the application of research is designed to facilitate or meet a need in healthcare. For example, the application of physics, chemistry, computing, engineering and materials science to the development of medical products is entirely appropriate.